Sodium ferulate attenuates ischaemic stroke by mediating the upregulation of thrombospondin-4 expression and combined treatment with bone marrow mesenchymal stem cells

Ischaemic stroke is one of the major diseases affecting human health, involving complex and diverse pathological mechanisms, including inflammatory response, oxidative stress and angiogenesis. Sodium ferulate (SF) exerts a protective effect on cerebral ischaemia/reperfusion and when combined with bo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental neurology 2025-03, Vol.385, p.115124, Article 115124
Hauptverfasser: Zhang, Qian, Zhang, Zhiqiang, Xiu, Yihong, Zou, Tianyu, Quan, Yaping
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 115124
container_title Experimental neurology
container_volume 385
creator Zhang, Qian
Zhang, Zhiqiang
Xiu, Yihong
Zou, Tianyu
Quan, Yaping
description Ischaemic stroke is one of the major diseases affecting human health, involving complex and diverse pathological mechanisms, including inflammatory response, oxidative stress and angiogenesis. Sodium ferulate (SF) exerts a protective effect on cerebral ischaemia/reperfusion and when combined with bone marrow mesenchymal stem cells (BMSCs), has a considerable therapeutic effect on brain injury in rats. Here, we speculate that SF also exerts cerebroprotective effects. In this study, we found that after SF intervention, thrombospondin 4 (TSP4) protein expression increased in oxygen glucose deprivation/restoration (OGD/R)–treated human brain microvascular endothelial cells (HBMECs). In addition, the transfection of sh-TPS4 reversed the inhibitory effects of SF on inflammatory infiltration, oxidative stress and apoptosis and promoted effects on cell migration and angiogenesis. BMSCs have strong proliferation ability and multi-directional differentiation potential and alleviate brain injury. We found that compared with wild-type BMSCs, the TSP4-modified BMSCs had a more considerable effect that alleviated OGD/R-induced cell injury. Furthermore, SF combined with TSP4-modified BMSCs promoted the repair of damaged OGD/R-treated HBMECs by activating the PI3K/AKT/mTOR pathway. In the rat middle cerebral artery occlusion (MCAO) model, the therapeutic effect of SF combined with BMSCs on brain injury in rats was better than that of SF alone, and the therapeutic effect of the TSP4-modified BMSCs was better than that of the wild-type BMSCs. In conclusion, our results showed that SF upregulated TSP4 expression and combined with BMSCs to promote repair of damaged OGD/R-treated HBMECs and improve ischaemic stroke in rats. •Sodium ferulate improves ischemic stroke.•Sodium ferulate upregulates thrombospondin-4 expression.•SF combined with TSP4 modified BMSCs improves ischemic stroke.
doi_str_mv 10.1016/j.expneurol.2024.115124
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3148495044</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014488624004503</els_id><sourcerecordid>3148495044</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1623-b7055060486343e2a6ef2fc27bec9c81d197f176976d1d176cb16504817d325a3</originalsourceid><addsrcrecordid>eNqFUU1v1DAQtRCIbgt_AXzkksV2HDs5VhW0lSpxaDlbjjPpeknsYDuU_UX8TWa1pVdO_pj35s28R8hHzraccfV5v4XfS4A1xWkrmJBbzhsu5Cuy4axjlZA1e002jHFZybZVZ-Q85z1jrJNCvyVndac5suoN-XMfB7_OdIS0TrYAtaVAWPGWqc9uZ2H2juaS4g-g_YHOMHhbfHikZQd0XRI8Hnk-BhpH_Etx7mNeYhh8qCTFKRPkfCzbMFCHVR9goCWBLTOEQp982dE-BqCzTSk-oUKG4HaH2U6oCzN1ME35HXkz2inD--fzgnz_-uXh6qa6-3Z9e3V5VzmuRF31mjUNU0y2qpY1CKtgFKMTugfXuZYPvNMj16rTasCHVq7nqkE410MtGltfkE-nvkuKP1fIxcxoA05gA8Q1m5rLVnbIkAjVJ6hLMecEo1mSxyUOhjNzTMnszUtK5piSOaWEzA_PImuPhr7w_sWCgMsTAHDVXx6Syc6jK2h-AlfMEP1_Rf4CADir-w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3148495044</pqid></control><display><type>article</type><title>Sodium ferulate attenuates ischaemic stroke by mediating the upregulation of thrombospondin-4 expression and combined treatment with bone marrow mesenchymal stem cells</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><creator>Zhang, Qian ; Zhang, Zhiqiang ; Xiu, Yihong ; Zou, Tianyu ; Quan, Yaping</creator><creatorcontrib>Zhang, Qian ; Zhang, Zhiqiang ; Xiu, Yihong ; Zou, Tianyu ; Quan, Yaping</creatorcontrib><description>Ischaemic stroke is one of the major diseases affecting human health, involving complex and diverse pathological mechanisms, including inflammatory response, oxidative stress and angiogenesis. Sodium ferulate (SF) exerts a protective effect on cerebral ischaemia/reperfusion and when combined with bone marrow mesenchymal stem cells (BMSCs), has a considerable therapeutic effect on brain injury in rats. Here, we speculate that SF also exerts cerebroprotective effects. In this study, we found that after SF intervention, thrombospondin 4 (TSP4) protein expression increased in oxygen glucose deprivation/restoration (OGD/R)–treated human brain microvascular endothelial cells (HBMECs). In addition, the transfection of sh-TPS4 reversed the inhibitory effects of SF on inflammatory infiltration, oxidative stress and apoptosis and promoted effects on cell migration and angiogenesis. BMSCs have strong proliferation ability and multi-directional differentiation potential and alleviate brain injury. We found that compared with wild-type BMSCs, the TSP4-modified BMSCs had a more considerable effect that alleviated OGD/R-induced cell injury. Furthermore, SF combined with TSP4-modified BMSCs promoted the repair of damaged OGD/R-treated HBMECs by activating the PI3K/AKT/mTOR pathway. In the rat middle cerebral artery occlusion (MCAO) model, the therapeutic effect of SF combined with BMSCs on brain injury in rats was better than that of SF alone, and the therapeutic effect of the TSP4-modified BMSCs was better than that of the wild-type BMSCs. In conclusion, our results showed that SF upregulated TSP4 expression and combined with BMSCs to promote repair of damaged OGD/R-treated HBMECs and improve ischaemic stroke in rats. •Sodium ferulate improves ischemic stroke.•Sodium ferulate upregulates thrombospondin-4 expression.•SF combined with TSP4 modified BMSCs improves ischemic stroke.</description><identifier>ISSN: 0014-4886</identifier><identifier>ISSN: 1090-2430</identifier><identifier>EISSN: 1090-2430</identifier><identifier>DOI: 10.1016/j.expneurol.2024.115124</identifier><identifier>PMID: 39710243</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>BMSCs ; HBMECs ; Ischaemic stroke ; Sodium ferulate ; Thrombospondin-4</subject><ispartof>Experimental neurology, 2025-03, Vol.385, p.115124, Article 115124</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1623-b7055060486343e2a6ef2fc27bec9c81d197f176976d1d176cb16504817d325a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.expneurol.2024.115124$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39710243$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Qian</creatorcontrib><creatorcontrib>Zhang, Zhiqiang</creatorcontrib><creatorcontrib>Xiu, Yihong</creatorcontrib><creatorcontrib>Zou, Tianyu</creatorcontrib><creatorcontrib>Quan, Yaping</creatorcontrib><title>Sodium ferulate attenuates ischaemic stroke by mediating the upregulation of thrombospondin-4 expression and combined treatment with bone marrow mesenchymal stem cells</title><title>Experimental neurology</title><addtitle>Exp Neurol</addtitle><description>Ischaemic stroke is one of the major diseases affecting human health, involving complex and diverse pathological mechanisms, including inflammatory response, oxidative stress and angiogenesis. Sodium ferulate (SF) exerts a protective effect on cerebral ischaemia/reperfusion and when combined with bone marrow mesenchymal stem cells (BMSCs), has a considerable therapeutic effect on brain injury in rats. Here, we speculate that SF also exerts cerebroprotective effects. In this study, we found that after SF intervention, thrombospondin 4 (TSP4) protein expression increased in oxygen glucose deprivation/restoration (OGD/R)–treated human brain microvascular endothelial cells (HBMECs). In addition, the transfection of sh-TPS4 reversed the inhibitory effects of SF on inflammatory infiltration, oxidative stress and apoptosis and promoted effects on cell migration and angiogenesis. BMSCs have strong proliferation ability and multi-directional differentiation potential and alleviate brain injury. We found that compared with wild-type BMSCs, the TSP4-modified BMSCs had a more considerable effect that alleviated OGD/R-induced cell injury. Furthermore, SF combined with TSP4-modified BMSCs promoted the repair of damaged OGD/R-treated HBMECs by activating the PI3K/AKT/mTOR pathway. In the rat middle cerebral artery occlusion (MCAO) model, the therapeutic effect of SF combined with BMSCs on brain injury in rats was better than that of SF alone, and the therapeutic effect of the TSP4-modified BMSCs was better than that of the wild-type BMSCs. In conclusion, our results showed that SF upregulated TSP4 expression and combined with BMSCs to promote repair of damaged OGD/R-treated HBMECs and improve ischaemic stroke in rats. •Sodium ferulate improves ischemic stroke.•Sodium ferulate upregulates thrombospondin-4 expression.•SF combined with TSP4 modified BMSCs improves ischemic stroke.</description><subject>BMSCs</subject><subject>HBMECs</subject><subject>Ischaemic stroke</subject><subject>Sodium ferulate</subject><subject>Thrombospondin-4</subject><issn>0014-4886</issn><issn>1090-2430</issn><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNqFUU1v1DAQtRCIbgt_AXzkksV2HDs5VhW0lSpxaDlbjjPpeknsYDuU_UX8TWa1pVdO_pj35s28R8hHzraccfV5v4XfS4A1xWkrmJBbzhsu5Cuy4axjlZA1e002jHFZybZVZ-Q85z1jrJNCvyVndac5suoN-XMfB7_OdIS0TrYAtaVAWPGWqc9uZ2H2juaS4g-g_YHOMHhbfHikZQd0XRI8Hnk-BhpH_Etx7mNeYhh8qCTFKRPkfCzbMFCHVR9goCWBLTOEQp982dE-BqCzTSk-oUKG4HaH2U6oCzN1ME35HXkz2inD--fzgnz_-uXh6qa6-3Z9e3V5VzmuRF31mjUNU0y2qpY1CKtgFKMTugfXuZYPvNMj16rTasCHVq7nqkE410MtGltfkE-nvkuKP1fIxcxoA05gA8Q1m5rLVnbIkAjVJ6hLMecEo1mSxyUOhjNzTMnszUtK5piSOaWEzA_PImuPhr7w_sWCgMsTAHDVXx6Syc6jK2h-AlfMEP1_Rf4CADir-w</recordid><startdate>202503</startdate><enddate>202503</enddate><creator>Zhang, Qian</creator><creator>Zhang, Zhiqiang</creator><creator>Xiu, Yihong</creator><creator>Zou, Tianyu</creator><creator>Quan, Yaping</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202503</creationdate><title>Sodium ferulate attenuates ischaemic stroke by mediating the upregulation of thrombospondin-4 expression and combined treatment with bone marrow mesenchymal stem cells</title><author>Zhang, Qian ; Zhang, Zhiqiang ; Xiu, Yihong ; Zou, Tianyu ; Quan, Yaping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1623-b7055060486343e2a6ef2fc27bec9c81d197f176976d1d176cb16504817d325a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>BMSCs</topic><topic>HBMECs</topic><topic>Ischaemic stroke</topic><topic>Sodium ferulate</topic><topic>Thrombospondin-4</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Qian</creatorcontrib><creatorcontrib>Zhang, Zhiqiang</creatorcontrib><creatorcontrib>Xiu, Yihong</creatorcontrib><creatorcontrib>Zou, Tianyu</creatorcontrib><creatorcontrib>Quan, Yaping</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Qian</au><au>Zhang, Zhiqiang</au><au>Xiu, Yihong</au><au>Zou, Tianyu</au><au>Quan, Yaping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sodium ferulate attenuates ischaemic stroke by mediating the upregulation of thrombospondin-4 expression and combined treatment with bone marrow mesenchymal stem cells</atitle><jtitle>Experimental neurology</jtitle><addtitle>Exp Neurol</addtitle><date>2025-03</date><risdate>2025</risdate><volume>385</volume><spage>115124</spage><pages>115124-</pages><artnum>115124</artnum><issn>0014-4886</issn><issn>1090-2430</issn><eissn>1090-2430</eissn><abstract>Ischaemic stroke is one of the major diseases affecting human health, involving complex and diverse pathological mechanisms, including inflammatory response, oxidative stress and angiogenesis. Sodium ferulate (SF) exerts a protective effect on cerebral ischaemia/reperfusion and when combined with bone marrow mesenchymal stem cells (BMSCs), has a considerable therapeutic effect on brain injury in rats. Here, we speculate that SF also exerts cerebroprotective effects. In this study, we found that after SF intervention, thrombospondin 4 (TSP4) protein expression increased in oxygen glucose deprivation/restoration (OGD/R)–treated human brain microvascular endothelial cells (HBMECs). In addition, the transfection of sh-TPS4 reversed the inhibitory effects of SF on inflammatory infiltration, oxidative stress and apoptosis and promoted effects on cell migration and angiogenesis. BMSCs have strong proliferation ability and multi-directional differentiation potential and alleviate brain injury. We found that compared with wild-type BMSCs, the TSP4-modified BMSCs had a more considerable effect that alleviated OGD/R-induced cell injury. Furthermore, SF combined with TSP4-modified BMSCs promoted the repair of damaged OGD/R-treated HBMECs by activating the PI3K/AKT/mTOR pathway. In the rat middle cerebral artery occlusion (MCAO) model, the therapeutic effect of SF combined with BMSCs on brain injury in rats was better than that of SF alone, and the therapeutic effect of the TSP4-modified BMSCs was better than that of the wild-type BMSCs. In conclusion, our results showed that SF upregulated TSP4 expression and combined with BMSCs to promote repair of damaged OGD/R-treated HBMECs and improve ischaemic stroke in rats. •Sodium ferulate improves ischemic stroke.•Sodium ferulate upregulates thrombospondin-4 expression.•SF combined with TSP4 modified BMSCs improves ischemic stroke.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39710243</pmid><doi>10.1016/j.expneurol.2024.115124</doi></addata></record>
fulltext fulltext
identifier ISSN: 0014-4886
ispartof Experimental neurology, 2025-03, Vol.385, p.115124, Article 115124
issn 0014-4886
1090-2430
1090-2430
language eng
recordid cdi_proquest_miscellaneous_3148495044
source Elsevier ScienceDirect Journals Complete - AutoHoldings
subjects BMSCs
HBMECs
Ischaemic stroke
Sodium ferulate
Thrombospondin-4
title Sodium ferulate attenuates ischaemic stroke by mediating the upregulation of thrombospondin-4 expression and combined treatment with bone marrow mesenchymal stem cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T17%3A05%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sodium%20ferulate%20attenuates%20ischaemic%20stroke%20by%20mediating%20the%20upregulation%20of%20thrombospondin-4%20expression%20and%20combined%20treatment%20with%20bone%20marrow%20mesenchymal%20stem%20cells&rft.jtitle=Experimental%20neurology&rft.au=Zhang,%20Qian&rft.date=2025-03&rft.volume=385&rft.spage=115124&rft.pages=115124-&rft.artnum=115124&rft.issn=0014-4886&rft.eissn=1090-2430&rft_id=info:doi/10.1016/j.expneurol.2024.115124&rft_dat=%3Cproquest_cross%3E3148495044%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3148495044&rft_id=info:pmid/39710243&rft_els_id=S0014488624004503&rfr_iscdi=true